1. A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma. (5th November 2020) Authors: Katada, Chikatoshi; Sugawara, Mitsuhiro; Hara, Hiroki; Fujii, Hirofumi; Nakajima, Takako Eguchi; Ando, Takayuki; Kojima, Takashi; Watanabe, Akinori; Sakamoto, Yasutoshi; Ishikawa, Hideki; Hosokawa, Ayumu; Hamamoto, Yasuo; Muto, Manabu; Tahara, Makoto; Koizumi, Wasaburo Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 2(2021) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A retrospective study of treatment for curative synchronous double primary cancers of the head and neck and the esophagus. Issue 5 (October 2018) Authors: Okamoto, Tabito; Katada, Chikatoshi; Komori, Shouko; Yamashita, Keishi; Miyamoto, Shunsuke; Kano, Koichi; Seino, Yutomo; Hosono, Hiroshi; Matsuba, Hiroki; Moriya, Hiromitsu; Sugawara, Mitsuhiro; Azuma, Mizutomo; Ishiyama, Hiromichi; Tanabe, Satoshi; Hayakawa, Kazushige; Koizumi, Wasaburo; Okamoto... Journal: Auris nasus larynx Issue: Volume 45:Issue 5(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Study protocol for SPARED trial: randomised non-inferiority phase III trial comparing dexamethasone on day 1 with dexamethasone on days 1–4, combined with neurokinin-1 receptor antagonist, palonosetron and olanzapine (5 mg) in patients receiving cisplatin-based chemotherapy. Issue 12 (17th December 2020) Authors: Minatogawa, Hiroko; Izawa, Naoki; Kawaguchi, Takashi; Miyaji, Tempei; Shimomura, Kazuhiro; Kazunori, Honda; Iihara, Hirotoshi; Ohno, Yasushi; Inada, Yusuke; Arioka, Hitoshi; Morita, Hajime; Hida, Naoya; Sugawara, Mitsuhiro; Katada, Chikatoshi; Nawata, Shuichi; Ishida, Hiroo; Tsuboya, Ayako; Tsuda... Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗